Immunotherapy for lung cancer in China typically costs from $4,200 to $9,800. The final price depends on the drug origin, hospital grade, and treatment cycles. Patients save approximately 92% compared to the US. In the US, the average price for similar treatment is $90,000. Most Chinese protocols include infusions, regular monitoring, and required laboratory tests.
Bookimed Expert Insight: Choosing specialized centers like Fuda Cancer Hospital in Guangzhou offers significant value for advanced cases. This JCI-accredited facility serves over 30,000 international patients and combines immunotherapy with unique local methods. These include NanoKnife and cryosurgery. This multidisciplinary approach often achieves results in late-stage cancer. It provides high-quality care at a fraction of Western costs.
| China | Turkey | Austria | |
| Immunotherapy for lung cancer | from $4,200 | from $18,000 | from $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for lung cancer journey.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Immunotherapy
Day 4 - Post-operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Please keep in mind that each patient"s journey is unique and can vary. Always follow the specific advice provided by your medical team.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.